Contribution of human leukocyte antigens to the antibody response to hepatitis B vaccination

Tissue Antigens

Volumn 50, Issue 1, 1997, Pages 8-14

  McDermott, A B ^a   Zuckerman, J N ^a   Sabin, C A ^a   Marsh, S G E ^a   Madrigal, J A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Hepatitis B surface antigen; Hepatitis B vaccination; HLA; HLA DQ2; HLA DQB1(*)02; HLA DR7; HLA DRB1(*)0701; Nonresponse; PreS1; PreS2

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; AGED; ALLELE; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DESIGN; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; HAPLOTYPE; HEPATITIS B; HUMAN; HUMAN EXPERIMENT; INTRAMUSCULAR DRUG ADMINISTRATION; NORMAL HUMAN; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SEROLOGY; VACCINATION; VACCINE PRODUCTION;

EID: 0030988851     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1997.tb02827.x     Document Type: Article

References (31)

1. Katkov WN, Dienstag JL Prevention and therapy of viral, hepatitis. Semin Liver Dis 1991: 11: 165-168.
2. Milich DR, Thornton GB, Neurath AR et al. Enhanced immunogenicity of the Pre-S region of hepatitis B surface antigen. Science 1985: 228: 1195-1198.
3. Milich DR, Hughes JL, McLachlan A et al. Importance of subtype in the immune to the response to the pre-S2 region of the hepatitis B surface antigen. J Immunol 1990: 144: 3535-3543.
4. Carman WF, Zanetti AR, Karayiannis P et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990: 336: 325-329.
5. Waters JA, Kennedy M, Voet P et al. Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant J Clin Invest 1992: 90: 2543-2547.
6. Rumi M, Colombo M, Boschini A et al. Suboptimal response to hepatitis B vaccine in drug users. Arch Intern Med 1991: 151: 574-578.
7. Wood RC, MacDonald KL, White KE et al. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA 1993: 270: 2935-2939.
8. Clements ML, Miskovsky E, Davison M et al. Effect of age on the immunogenicity of yeast recombinant hepatitis B vaccines containing surface antigen (S) or preS2+S antigens. J Infect Dis 1994: 170: 510-16.
9. Del Canho R, Grosheidi PM, Schalm SW et al. Failure of neonatal, hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. J Hepatol 1994: 20: 483-486.
10. Struve J, Aronsson B, Frenning B et al. Response to a booster dose 18 months after a low anti-HBs response (10-99 IU/1) to three doses of intradermally or intramuscular administered recombinant hepatitis B vaccine. Infection 1995: 23: 42-45.
11. Walker M, Szmuness W, Stevens CE et al. Genetics of anti-HBs responsiveness: HLA DR7 and non-responsiveness to hepatitis B vaccination. Transfusion 1981: 21: 601.
12. Marescot MR, Budkowska A, Pillot J et al. HLA linked immune response to S and pre-S2 gene products in hepatitis B vaccination. Tissue Antigens 1989: 33: 495-500.
13. Kruskall MS, Alper CA, Awdeh Z et al. The immune response to hepatitis B vaccine in humans: inheritance patterns in families. J Exp Med 1992: 175: 495-502.
14. Desombere I, Hauser P, Rosseau R et al. Nonresponders to hepatitis B vaccine can present envelope particles to T lymphocytes. J Immunol 1995: 154: 520-529.
15. Kidd-Ljunggren K, Courouce A-M, Oberg M et al. Genetic conservation within subtypes in the hepatitis B virus pre-S2 region. J Gen Virol 1994: 75: 1485-1490.
16. Craven DE, Awdeh ZL, Kunches LM et al. Nonresponsivenes to hepatitis B vaccine in health care workers. Ann Intern Med 1986: 105: 356-360.
17. Alper CA, Kruskhall MS, Marcus-Bagley D et al. Genetic prediction of non-response to hepatitis B vaccine. N Engl J Med 1989: 321: 708-12.
18. Hatae K, Kimura A, Okubo R et al. Genetic control of nonresponsiveness to hepatitis B virus vaccine by an extended haplotype. Eur J Immunol 1992: 22: 1899-1905.
19. Imanishi T, Akaza T, Kimura A, Tokungaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991: Proceedings of the Eleventh International, Histocompatibility Workshop and Conference. Oxford: Oxford University Press, 1992: 1065-1220.
20. Jordan F, McWhinnie AJ, Turner S et al. Comparison of HLA-DRB1 typing by DNA-RFLP, PCR-SSO and PCR-SSP methods and their application in providing matched unrelated donors for bone marrow transplantation. Tissue Antigens 1995: 45: 103-110.
21. Svejgaard A, Jersild C, Staub-Neilsen et al. HL-A antigens and disease: statistical and genetical considerations. Tissue Antigens 1974: 4: 95-105.
22. Hall M A, Lanchbury J S, Lee J S et al. HLA-DQ2 second-domain polymorphisms may explain increased trans-associated risk in celiac disease and dermatitis herpetiformis. Hum Immunol 1993: 38: 284-292.
23. Milich DR. Immune response to Hepatitis B virus proteins: relevance of the murine model. Semin Liver Dis 1991: 11(2): 93-111.
24. Ferrari C, Cavalli A, Penna A et al. Fine specificity of the human T-cell response to the hepatitis virus pre-S1 antigen. Gastroenterology 1992: 103: 255-263.
25. Suzuki H, Iino S, Shiraki K et al. Safety and efficacy of a recombinant yeast-derived hepatitis B vaccine (TGP-943): phase 1, 2 and 3 clinical testing. Vaccine 1994: 12: 1090-1095.
26. Wantanbe H, Okumura M, Hirayama K et al. HLA-Bw54-DRw53-DQw4 haplotype controls nonresponsiveness to hepatitis B surface antigen via CD8 positive suppressor T cells. Tissue Antigens 1990: 36: 69-74.
27. Matsushita S, Muto M, Suemura M et al. HLA linked non-responsiveness to Cryptomeria japonica pollen antigen. J Immunol 1987: 138: 109-115.
28. Kamikawaji N, Fujisawa K, Yoshizumi H et al. HLA-DQ restricted CD4 T-cells specific to streptococcal antigen present in low but not in high responders. J Immunol 1991: 146: 2560-2567.
29. Ottenhoff THM, Walford C, Nishimura Y et al. HLA-DQ molecules and the control of Mycobacterium leprae-specific T cell nonresponsiveness in lepromatous leprosy patients. Eur J Immunol 1990: 20: 2347-2350.
30. Sasazuki T, Kikuchi I, Hirayama K et al. HLA-linked immune suppression in humans. Immunology 1989: suppl 2: 21-24.
31. Kwok WW, Nepom GT, Raymond FC HLA-DQ polymorphisms are highly selective for peptide binding interactions. J Immunol 1995: 155: 2468-2476.